The TOMMORROW study: Design of an Alzheimer's disease delay-of-onset clinical trial

INTRODUCTION: Alzheimer's disease (AD) is a continuum with neuropathologies manifesting years before clinical symptoms; thus, AD research is attempting to identify more disease-modifying approaches to test treatments administered before full disease expression. Designing such trials in cognitiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Burns, Daniel K., Chiang, Carl, Welsh-Bohmer, Kathleen A., Brannan, Stephen K., Culp, Meredith, O'Neil, Janet, Runyan, Grant, Harrigan, Patrick, Plassman, Brenda L., Lutz, Michael, Lai, Eric, Haneline, Stephen, Yarnall, David, Yarbrough, Deborah, Metz, Craig, Ponduru, Sridevi, Sundseth, Scott, Saunders, Ann M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Featured Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838537/
https://www.ncbi.nlm.nih.gov/pubmed/31720367
http://dx.doi.org/10.1016/j.trci.2019.09.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838537/
https://www.ncbi.nlm.nih.gov/pubmed/31720367
http://dx.doi.org/10.1016/j.trci.2019.09.010

Ejemplares similares